A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 22, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Healthy Volunteer

Interventions

DRUG

ABBV-142

Intravenous (IV) Infusion

DRUG

ABBV-142

Subcutaneous (SC) Injection

DRUG

Placebo

IV Infusion

DRUG

Placebo

SC Injection

Trial Locations (1)

RECRUITING

Acpru /Id# 271899, Grayslake